| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $176.6M | -13.6% |
| Cost of Revenue | $134.8M | -21.9% |
| Gross Profit | $41.8M | +31.7% |
| R&D Expense | $13.0M | +9.1% |
| SG&A Expense | $13.9M | +1.2% |
| Operating Income | $8.8M | +221.2% |
| Interest Expense | $1.1M | +74.9% |
| Pre-tax Income | $11.1M | +284.1% |
| Income Tax | $1.6M | -37.3% |
| Net Income | $11.8M | +581.4% |
| EPS (Basic) | $0.13 | +533.3% |
| EPS (Diluted) | $0.13 | +533.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.7M | +44.8% |
| Short-term Investments | $4.2M | — |
| Accounts Receivable | $32.9M | +15.0% |
| Inventory | $22.9M | -31.6% |
| Current Assets | $141.4M | +10.1% |
| Total Assets | $302.2M | +7.5% |
| Current Liabilities | $171.7M | +7.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $39.7M | -14.6% |
| Capital Expenditures | $17.2M | -44.8% |
| Investing Cash Flow | -$23.4M | +44.6% |
| Financing Cash Flow | -$11.7M | -162.8% |
| Free Cash Flow | $22.5M | +46.5% |
| Total Liabilities |
| $182.2M |
| +8.6% |
| Stockholders' Equity | $121.7M | +7.8% |